Skip to main content
Caplight Logo









Metacarpal

Metacarpal

Private
EdinburghHealthcare & Life Scienceshttps://metacarpalprosthetics.com/

Last Round

Seed

Aug 27, 2024

Total Funding Raised

$1.78M

Company Overview

Metacarpal is a medical technology company that develops and manufactures body-powered, multi-articulating prosthetic hands.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

upper-limb prosthesisbody-powered prosthetic3D-printed prostheticsmechanical prostheticbionic handadditive manufacturingmedical devicecustom prostheticslimb differencetransradial amputationprosthetic handassistive technologyprosthetic fitting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metacarpal Comparables

Compare Metacarpal with similar companies based on industry and business-model similarity.

Metacarpal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Unlimited Tomorrow
84%
Limber Prosthetics & Orthotics, Inc.
81%
Open Bionics
81%

Metacarpal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 27, 2024
GrantJan 16, 2023
Pre SeedDec 20, 2022
GrantMay 1, 2022
Pre SeedApr 1, 2022
Grant
Apr 1, 2022

Key People

Founding team and executive leadership

Fergal Mackie

Chief Executive Officer

Executive Team

Metacarpal Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2022

    Secured $50K in grant funding.

Metacarpal Filings

Explore SEC and related filing metadata, where available.

Metacarpal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Metacarpal's valuation, stock price, and market status.

Is Metacarpal a public or private company?

Metacarpal is a private company.

What is the current stock price of Metacarpal?

Metacarpal is a private company with no public stock price. No recent secondary market data is available.

How much is Metacarpal worth (valuation)?

Valuation information for Metacarpal is not publicly available.

Can I buy Metacarpal stock?

Metacarpal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Metacarpal's last funding round?

Metacarpal's most recent funding round was Seed on August 27, 2024.

Who are the main investors in Metacarpal?

Key investors in Metacarpal include Worth Capital, University of Strathclyde, SIS Ventures, Oxford Technology.

Will Metacarpal IPO soon?

No public IPO plans have been announced for Metacarpal.

How can I track Metacarpal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Metacarpal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdinburgh
Employee Range11
Year Founded2020
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?